BL04 + BB01 + BR03™ (PROBIAL VISION UVEA)

Blend
Blend
On this page

Ophthalmology

Recurrent acute anterior uveitis

Functionality

Supports healthy ocular inflammatory balance

Dosage / Clinical Study

1) 1 billion CFU BL04 + 1 billion CFU BB01 + 1 billion CFU BR03™

Available Formats

Blend

Finished dosage form

Scientific Support
Clinical studies

1) Napolitano P. et al. Probiotic Supplementation Improved Acute Anterior Uveitis of 3-Year Duration: A Case Report. Am J Case Rep. 2021 Jul 17;22:e931321. Doi: 10.12659/AJCR.931321 [Case Study] 

In vitro studies

a) Amoruso A. et al. A Systematic Evaluation of the Immunomodulatory and Functional Properties of Probiotic Bifidobacterium Breve BR03 (DSM 16604) Lactobacillus plantarum LP01 (LMG P-21021). J Prob Health. 2019;  7:214. Doi: 10.35248/2329-8901.19.7.214 [BR03 strain data]

b) Nicola S. et al. Interaction between probiotics and human immune cells: the prospective anti-inflammatory activity of Bifidobacterium breve BR03. AgroFOOD, 2010; 21(2):S44-47 [BR03 strain data]

Associations